Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. CT ORDER Other Confidential Order
  5. 10-Q Report Quarterly Report
  6. 10-Q/A Report 10-Q/A
  7. 8-K Event Results of operations
  8. DEF 14A Proxy Proxy Statement
  9. 8-K Event Material agreement
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 4 Open-market buy EVP, Dev and Corp Strategy bought 7,500 shares at an average $15.72 ($117,875)
  12. CT ORDER Other Confidential Order
  13. UPLOAD Other SEC-generated Letter
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. 10-K Report Annual Report
  18. POSASR Other POSASR
  19. 8-K Event Results of operations
  20. 5 Insider Annual Insider Trading Report

Page 26 of 37 · 725 filings